Cargando...

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

BACKGROUND: Testing of vaccine candidates to prevent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased incidences of illness and death from coronavirus disease 2019 (Covid-19) have been associated with an older age. METHO...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:N Engl J Med
Autores principales: Anderson, Evan J., Rouphael, Nadine G., Widge, Alicia T., Jackson, Lisa A., Roberts, Paul C., Makhene, Mamodikoe, Chappell, James D., Denison, Mark R., Stevens, Laura J., Pruijssers, Andrea J., McDermott, Adrian B., Flach, Britta, Lin, Bob C., Doria-Rose, Nicole A., O’Dell, Sijy, Schmidt, Stephen D., Corbett, Kizzmekia S., Swanson, Phillip A., Padilla, Marcelino, Neuzil, Kathy M., Bennett, Hamilton, Leav, Brett, Makowski, Mat, Albert, Jim, Cross, Kaitlyn, Edara, Venkata Viswanadh, Floyd, Katharine, Suthar, Mehul S., Martinez, David R., Baric, Ralph, Buchanan, Wendy, Luke, Catherine J., Phadke, Varun K., Rostad, Christina A., Ledgerwood, Julie E., Graham, Barney S., Beigel, John H.
Formato: Artigo
Lenguaje:Inglês
Publicado: Massachusetts Medical Society 2020
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7556339/
https://ncbi.nlm.nih.gov/pubmed/32991794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2028436
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!